ENvue Medical, Inc. short interest in 2022
In 2022, ENvue Medical, Inc.'s disclosed short interest ran from 0.76% of shares outstanding on 14 Jan 2022 to 0.61% on 30 Dec 2022, a change of -0.15 percentage points. The year's high was 2.51% on 14 Apr 2022 and its low 0.49% on 15 Aug 2022, averaging 1.34% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.43 days on 31 May 2022. Full history: ENvue Medical, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 0.76% (14 Jan 2022)
- End of year
- 0.61% (30 Dec 2022)
- Change
- -0.15 pp
- High
- 2.51% (14 Apr 2022)
- Low
- 0.49% (15 Aug 2022)
- Average
- 1.34%
- Highest days to cover
- 5.43 (31 May 2022)
- SEC filings marked
- 5
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 0.76% | 1.00 | |
| 31 Jan 2022 | 0.88% | 1.00 | |
| 15 Feb 2022 | 1.16% | 1.00 | |
| 28 Feb 2022 | 1.14% | 1.53 | |
| 15 Mar 2022 | 1.49% | 2.31 | |
| 31 Mar 2022 | 2.04% | 1.00 | |
| 14 Apr 2022 | 2.51% | 1.00 | |
| 29 Apr 2022 | 1.49% | 2.23 | 10-K filed |
| 13 May 2022 | 1.94% | 1.96 | |
| 31 May 2022 | 2.11% | 5.43 | 10-Q filed, results (8-K) |
| 15 Jun 2022 | 1.03% | 3.06 | |
| 30 Jun 2022 | 1.59% | 3.28 | |
| 15 Jul 2022 | 1.49% | 3.07 | |
| 29 Jul 2022 | 1.46% | 3.71 | |
| 15 Aug 2022 | 0.49% | 1.27 | 10-Q filed |
| 31 Aug 2022 | 0.84% | 1.00 | |
| 15 Sep 2022 | 0.88% | 2.33 | |
| 15 Nov 2022 | 1.75% | 4.21 | 10-Q filed |
| 15 Dec 2022 | 1.15% | 1.00 | |
| 30 Dec 2022 | 0.61% | 1.00 |
See also: ENvue Medical, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.